Info & Diagnostics:

Patients

The PAP Foundation is a proud partner of the RLDC.

Clinical Trials

Register

Blood Test

Currently Enrolling 

Clinical Trials 

for PAP Patients
& Clinicians

___________________________________________

Trial #1

Savara Pharma will soon start enrolling PAP patients for their 'IMPALA 2' Phase 3 clinical trial involving  MOLGRADEX (inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF) for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP). 


Additional information will be posted here once it is released by Savara.

___________________________________________

Trial #2

Phase 1 oral drug Pioglitazone trials are NOW ACTIVE for the East Coast (Cincinnati) PAP Clinical Center ONLY - CLICK HERE FOR DETAILS

___________________________________________

If you suffer from PAP and are interested in learning about the clinical trials, or would like to receive updates and news about the fight against PAP, please complete the below to be on our contact list.

Sign up with the National PAP Registry:

 

You are eligible to sign up for the
National PAP Registry IF:

 

(1) You have been diagnosed with PAP by a doctor and (2) you are able to provide written informed consent.

The PURPOSE of the PAP Registry is to assemble and coordinate the PAP community to accelerate research and improve our understanding, diagnosis, and treatment of PAP.

If you are eligible and would like to participate, please 

CLICK HERE

and follow the instructions on the

Registry Page .

New PAP Blood Spot Diagnostic Test:

[Instructions & Procedures to obtain, complete & submit test - Coming Soon

 

RAW PAPKit Instructions can be accessed by CLICKING HERE]

© 2019 by the PAP Foundation 

Contact us:
TEL: (844) CURE-PAP

FAX: (513) 636-3723

email: info@papfoundation.org

​Find us: 

3333 Burnet Avenue, CCRF R4029

Cincinnati OH 45229-3039, USA

​TAX ID#: 27-0094262